We aim to ensure relevant, accurate and timely information is available to our investors and the rest of the financial community. Genmab is listed on the Nasdaq Copenhagen and our communication with the capital markets complies with the disclosure rules and regulations of this exchange.
As part of our Investor Relations activities we:
- Observe quiet periods before issuing financial reports
- Hold regular analyst and investor meetings to discuss our financial reports or other important news events
- Provide financial guidance for the year
- Maintain an updated website which includes corporate documents, financial reports, stock information and other information on the company, including our products and technology
- Have a dedicated IR contact person.